Talk:Rasagiline

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Rasagiline.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

This is the talk page for discussing improvements to the Rasagiline article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

comment1[edit]

Corrected introduction to be in accordance with ref. 1, which says that trials to determine whether rasagiline is MAO-B selective have NOT YET been conducted. 208.102.122.87 (talk) 02:27, 22 January 2008 (UTC)[reply]

This article is biased and appears to be written by the manufacturer[edit]

Aziltec (Rasagiline) is an MAO inhibitor. Pharmacists in the USA who see this drug being prescribed will immediately check for contraindications of MAO inhibitors with other drugs and that is a very long list. Aziltec is one of the few remaining MAO inhibitors still in use. The "Safety" section of this article should be expanded. Heaven forbid someone take Aziltec with a serotonin reuptake inhibitor like Paxil or Klonopin. Frank Layden (talk) 00:21, 12 December 2013 (UTC)[reply]

Yes it did suck. I just worked it over. Jytdog (talk) 05:48, 7 February 2016 (UTC)[reply]

Is this really an MAO-B?[edit]

The study provided showing that this is an MAO-B was written by the manufacturer.

"and appears to be especially useful in dealing with non-motor symptoms like fatigue" that doesn't seem right

"Side effects when the drug is taken alone include flu-like symptoms, joint pain, depression, stomach upset, headache, dizziness, and insomnia" this sounds a lot like the effects of serotonin

Also look at the molecular structure it's literally shaped like a serotonin molecule

Whereas selegiline which definitely is a dopaminergic drug is shaped like a dopamine molecule.

Something doesn't seem quite right with this medication. JoeC46 (talk) 13:03, 11 May 2023 (UTC)[reply]